A DNA functionalized metal-organic framework combined with magnesium peroxide nanoparticles: targeted and enhanced photodynamic therapy
Photodynamic therapy (PDT) has become a promising therapeutic approach in clinical practices. How to improve the efficiency of PDT is still a research hotspot due to tumor hypoxia and insufficient aggregation of photosensitizers (PSs) at the tumor site. Here, we report an aptamer functionalized meta...
Gespeichert in:
Veröffentlicht in: | Materials chemistry frontiers 2022-03, Vol.6 (7), p.956-965 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Photodynamic therapy (PDT) has become a promising therapeutic approach in clinical practices. How to improve the efficiency of PDT is still a research hotspot due to tumor hypoxia and insufficient aggregation of photosensitizers (PSs) at the tumor site. Here, we report an aptamer functionalized metal-organic framework combined with magnesium peroxide nanoparticles (Hf-MOF-MgO
2
/DNA) to target and enhance PDT. Hf-MOF-MgO
2
/DNA could produce oxygen in sufficient quantities, solving the hypoxia problem and enhancing PDT. The aptamer simultaneously and specifically targets tumor cells, performing targeted therapy. After PDT treatment
in vitro
, the Hf-MOF-MgO
2
/DNA platform functionalized by the aptamer of 4T1 cells specifically targeted the cell and achieved a survival rate of 15.15% for the 4T1 cell, while the survival rate for the A549 cell was 28.69% under the same conditions. This work highlights a rational design for efficient reactive oxygen generation
in situ
and effective PS accumulation in tumors, opening new horizons for the development of theranostic nanomedicines.
A self-supplying O
2
nanosystem (Hf-MOF-MgO
2
/DNA) based on a DNA functionalized MOF combined with magnesium peroxide nanoparticles was constructed. This nanosystem can be used for targeted PDT with a significantly enhanced therapeutic efficacy. |
---|---|
ISSN: | 2052-1537 2052-1537 |
DOI: | 10.1039/d1qm01475g |